Shilpa Medicare Limited (BOM:530549)
India · Delayed Price · Currency is INR 611.55
+7.95 (1.32%)
At close: Jul 31, 2026
Shilpa Medicare Ratios and Metrics
Market cap in millions INR. Fiscal year is April - March.
Millions INR. Fiscal year is Apr - Mar.
Total Valuation
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
| 119,608 | 68,190 | 57,550 | 40,046 | 19,908 | 34,473 | |
Market Cap Growth | 50.16% | 18.49% | 43.71% | 101.16% | -42.25% | 26.68% |
Enterprise Value | 125,755 | 73,916 | 62,197 | 48,372 | 27,280 | 42,348 |
Last Close Price | 611.55 | 348.65 | 331.10 | 230.40 | 114.54 | 197.77 |
Price Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
PE Ratio | 49.16 | 28.02 | 73.51 | 125.64 | - | 56.83 |
Forward PE | 45.98 | 21.57 | 32.18 | 19.99 | 19.99 | 29.04 |
PS Ratio | 7.77 | 4.43 | 4.47 | 3.47 | 1.89 | 3.01 |
PB Ratio | 4.62 | 2.63 | 2.44 | 2.23 | 1.12 | 1.90 |
P/TBV Ratio | 6.31 | 3.60 | 3.18 | 3.08 | 1.54 | 2.50 |
P/OCF Ratio | 34.95 | 19.93 | 43.54 | 29.30 | 11.07 | 32.79 |
PEG Ratio | 1.57 | 2.43 | 2.43 | 2.43 | 2.43 | 2.43 |
EV Ratios
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
EV/Sales Ratio | 8.17 | 4.80 | 4.83 | 4.20 | 2.59 | 3.69 |
EV/EBITDA Ratio | 27.83 | 17.00 | 20.35 | 20.64 | 31.52 | 21.47 |
EV/EBIT Ratio | 37.87 | 23.47 | 31.83 | 37.46 | - | 35.17 |
Financial Efficiency
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Debt / Equity Ratio | 0.26 | 0.26 | 0.25 | 0.52 | 0.45 | 0.38 |
Debt / EBITDA Ratio | 1.52 | 1.52 | 1.92 | 3.99 | 9.17 | 3.49 |
Net Debt / Equity Ratio | 0.24 | 0.24 | 0.24 | 0.50 | 0.44 | 0.36 |
Net Debt / EBITDA Ratio | 1.41 | 1.41 | 1.84 | 3.87 | 9.00 | 3.34 |
Net Debt / FCF Ratio | -21.61 | -21.61 | -5.04 | -18.94 | -16.67 | -2.90 |
Asset Turnover | 0.44 | 0.44 | 0.40 | 0.39 | 0.36 | 0.42 |
Inventory Turnover | 1.29 | 1.29 | 1.31 | 1.33 | 1.36 | 1.28 |
Quick Ratio | 0.68 | 0.68 | 0.88 | 0.72 | 0.53 | 0.81 |
Current Ratio | 1.31 | 1.31 | 1.46 | 1.26 | 0.98 | 1.45 |
Return on Equity (ROE) | 9.82% | 9.82% | 3.76% | 1.79% | -1.73% | 3.70% |
Return on Assets (ROA) | 5.61% | 5.61% | 3.81% | 2.69% | -0.12% | 2.73% |
Return on Invested Capital (ROIC) | 8.35% | 8.47% | 4.44% | 2.89% | -0.21% | 3.06% |
Return on Capital Employed (ROCE) | 11.00% | 11.00% | 7.40% | 5.40% | -0.30% | 5.30% |
Yields
Fiscal Year | Current | FY 2026 | FY 2025 | FY 2024 | FY 2023 | FY 2022 |
|---|---|---|---|---|---|---|
Period Ending | Jul '26 Jul 30, 2026 | Mar '26 Mar 31, 2026 | Mar '25 Mar 31, 2025 | Mar '24 Mar 31, 2024 | Mar '23 Mar 31, 2023 | Mar '22 Mar 31, 2022 |
Earnings Yield | 2.03% | 3.57% | 1.36% | 0.80% | -1.63% | 1.76% |
FCF Yield | -0.24% | -0.42% | -1.94% | -1.20% | -2.35% | -6.58% |
Dividend Yield | 0.10% | 0.17% | 0.15% | - | - | 0.28% |
Payout Ratio | 4.02% | 4.02% | - | - | - | 14.78% |
Buyback Yield / Dilution | -0.38% | -0.38% | -12.24% | - | -3.91% | -2.46% |
Total Shareholder Return | -0.28% | -0.21% | -12.09% | - | -3.91% | -2.19% |